US clinical-stage genetic meds company MeiraGTx Holdings has released positive top-line data from its clinical bridging study ...

Johnson & Johnson (NYSE: JNJ) has reported revenue of $22.5 billion for the third quarter of 2024, a 5.2% increase ...

Novartis halted its Phase II IPF trial for LTP001, citing non-safety reasons. This move aligns with its strategy to ...

Akeso Biopharma (HKEX: 9926) raised $250M via share placement, boosting cash reserves to over $1B. Funds will fast-track ...

US pharma major Eli Lilly has released new data demonstrating more patients with moderately to severely active Crohn's ...

Eli Lilly (NYSE: LLY) plans to invest $206M to expand its Suzhou, China site for Type 2 diabetes and obesity drugs. The ...

Almirall has completed the decentralized EU regulatory procedure for efinaconazole (Jublia) for onychomycosis. The final step ...

French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 ...

South Korea-based biosimilar drug developer Celltrion today announced two-year results of subcutaneous infliximab (CT-P13 SC) ...

Antibody-drug conjugates (ADCs) combine antibodies with cytotoxic drugs to target cancer cells while minimizing damage to ...

Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. This strategic ...

Danish dermatology focused LEO Pharma has announced the launch of Anzupgo (delgocitinib) cream in Germany for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for ...